Company registration number 13858192 (England and Wales)
ANAVO CARE (BRAMPTON) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
ANAVO CARE (BRAMPTON) LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 11
ANAVO CARE (BRAMPTON) LIMITED
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
5
177,263
207,227
Current assets
Stocks
2,370
2,405
Debtors
6
664,195
566,605
Cash at bank and in hand
38,401
191,689
704,966
760,699
Creditors: amounts falling due within one year
7
(2,515,617)
(1,937,666)
Net current liabilities
(1,810,651)
(1,176,967)
Total assets less current liabilities
(1,633,388)
(969,740)
Provisions for liabilities
8
(45,545)
(38,052)
Net liabilities
(1,678,933)
(1,007,792)
Capital and reserves
Called up share capital
9
1
1
Profit and loss reserves
(1,678,934)
(1,007,793)
Total equity
(1,678,933)
(1,007,792)
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 22 December 2025 and are signed on its behalf by:
Mr James Braganza
Director
Company registration number 13858192 (England and Wales)
ANAVO CARE (BRAMPTON) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 April 2023
1
(447,621)
(447,620)
Year ended 31 March 2024:
Loss and total comprehensive income
-
(560,172)
(560,172)
Balance at 31 March 2024
1
(1,007,793)
(1,007,792)
Year ended 31 March 2025:
Loss and total comprehensive income
-
(671,141)
(671,141)
Balance at 31 March 2025
1
(1,678,934)
(1,678,933)
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information
Anavo Care (Brampton) Limited is a private company limited by shares incorporated in England and Wales. The registered office is First Floor, 15-17 The Crescent, Leatherhead, Surrey, KT22 8DY.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
1.2
Going concern
The directors have considered the appropriateness of the going concern basis in preparing the financial statements of the company for the year ending 31 March 2025. As at 31 March 2025 the company made a loss of £671,141 (2024: £560,172) and had net liabilities of £1,678,933 (2024: £1,007,792). The company's immediate parent undertaking, has agreed to provide continuing financial support to the company, for at least twelve months after the date of approval by the directors of the financial statements for the year ended 31 March 2025. To enable the company to meet its liabilities as they fall due and as such the directors believe that the company is well placed to manage its business risks successfully. Thus the directors continue to adopt the going concern basis in preparing the financial statements.true
1.3
Turnover
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Revenue is recognised on a time-elapsed basis as the principal performance obligation is to provide bed capacity. Units of care under these contracts are typically provided on a daily basis for customers for the provision of care and support services and providing activities organised by the company.
1.4
Tangible fixed assets
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings
5 years on cost
Computers
3 years on cost
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.9
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 6 -
1.11
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.12
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.13
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Depreciation
Depreciation is provided so as to write down the assets to their residual values over their estimated useful lives as set out in the company’s accounting policy. The selection of these estimated lives requires management judgement. Useful lives are regularly reviewed by management in assessing useful lives and depreciation charges in the financial statements, which are reviewed accordingly when considering any changes.
Accruals
The company has entered into a short-term arrangement to lease of a Care Home. The lease is a classified as an operating lease. Management has considered the requirements in FRS 102 for interest free period and the annual increase in lease rental costs. Management has estimated the rental increment based on estimates indicated within the lease agreement.
Deferred Tax
Deferred tax typically arises as a result of timing differences that arise between taxable profits and total comprehensive income as reported in the financial statements. When a company claims capital allowances, it effectively reduces taxable profits. Capital allowances calculations include estimations such as the useful life of an asset, which requires management judgement. These are reviewed accordingly when considering any changes.
Accrued Income
The amount of accrued income recognised at the balance sheet date requires management judgement in assessing the stage of completion of services provided but not yet invoiced. Estimates are based on contract terms, residence reports, historical recovery and expected residence approval. These estimates involve uncertainty and may result in adjustments to revenue in future periods.
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
93
89
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
3
Employees
(Continued)
- 8 -
Their aggregate remuneration comprised:
2025
2024
£
£
Wages and salaries
2,023,641
1,691,725
Social security costs
176,184
127,165
Pension costs
38,565
56,211
2,238,390
1,875,101
4
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
11
Amortisation and impairment
At 1 April 2024 and 31 March 2025
11
Carrying amount
At 31 March 2025
At 31 March 2024
5
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 April 2024
218,644
33,683
252,327
Additions
28,070
28,070
At 31 March 2025
246,714
33,683
280,397
Depreciation and impairment
At 1 April 2024
34,778
10,322
45,100
Depreciation charged in the year
46,806
11,228
58,034
At 31 March 2025
81,584
21,550
103,134
Carrying amount
At 31 March 2025
165,130
12,133
177,263
At 31 March 2024
183,866
23,361
207,227
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 9 -
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
302,832
225,578
Other debtors
361,363
341,027
664,195
566,605
7
Creditors: amounts falling due within one year
2025
2024
£
£
Other borrowings
216,500
Trade creditors
149,557
251,423
Amounts owed to undertakings in which the company has a participating interest
38,868
Taxation and social security
40,295
33,094
Other creditors
64,111
63,000
Accruals and deferred income
2,222,786
1,373,649
2,515,617
1,937,666
8
Provisions for liabilities
2025
2024
£
£
Deferred tax liabilities
45,545
38,052
9
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
1
1
1
1
10
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
10
Audit report information
(Continued)
- 10 -
Opinion
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
Senior Statutory Auditor:
Bobby Gurdep Bhogal ACA ACCA ATT
Statutory Auditor:
Arnold Hill & Co LLP
Date of audit report:
22 December 2025
11
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases relating to the leased property, as follows:
2025
2024
£
£
Within one year
496,125
496,125
Between two and five years
2,245,279
2,245,279
In over five years
36,484,110
36,980,235
39,225,514
39,721,639
12
Related party transactions
Transactions with related parties
During the year entered into the following transactions with subsidiary undertaking and associated companies:
Anavo Capital Ltd
Anavo Care Ltd
Anavo Care (Crewe) Ltd
Hestia Care Ltd
Craysell Ltd
ANAVO CARE (BRAMPTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
12
Related party transactions
(Continued)
- 11 -
The following amounts were outstanding at the reporting end date:
2025
2024
Amounts due to related parties
£
£
Anavo Care (Crewe)
82
-
Anavo Capital Ltd
63,000
63,000
Hestia Care Ltd
29,084
8,594
Craysell Ltd
9,784
-
101,950
71,594
The following amounts were outstanding at the reporting end date:
2025
2024
Amounts due from related parties
£
£
Anavo Care Ltd
231,565
250,000
Hesta Care Ltd and Craysell Ltd are associated companies through common ownership.
13
Parent company
The immediate parent company is Anavo Care Ltd, a company incorporated in England and Wales.
The parent undertaking of the only group for which group financial statements are drawn up and of which the
company is a member is Anavo Capital Limited, a company incorporated in England and Wales.
Group financial statements are prepared and are available from Companies House, Crown Way, Cardiff, CF14
3UZ
2025-03-312024-04-01falsefalsefalse22 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityEdward Guy MOOREJamie Oliver BraganzaThomas Allan Brookes138581922024-04-012025-03-31138581922025-03-31138581922024-03-3113858192core:FurnitureFittings2025-03-3113858192core:ComputerEquipment2025-03-3113858192core:FurnitureFittings2024-03-3113858192core:ComputerEquipment2024-03-3113858192core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3113858192core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3113858192core:WithinOneYear2025-03-3113858192core:WithinOneYear2024-03-3113858192core:CurrentFinancialInstruments2025-03-3113858192core:CurrentFinancialInstruments2024-03-3113858192core:ShareCapital2025-03-3113858192core:ShareCapital2024-03-3113858192core:RetainedEarningsAccumulatedLosses2025-03-3113858192core:RetainedEarningsAccumulatedLosses2024-03-3113858192core:ShareCapital2023-03-3113858192core:RetainedEarningsAccumulatedLosses2023-03-3113858192core:ShareCapitalOrdinaryShareClass12025-03-3113858192core:ShareCapitalOrdinaryShareClass12024-03-3113858192bus:Director22024-04-012025-03-3113858192core:RetainedEarningsAccumulatedLosses2023-04-012024-03-31138581922023-04-012024-03-3113858192core:RetainedEarningsAccumulatedLosses2024-04-012025-03-3113858192core:FurnitureFittings2024-04-012025-03-3113858192core:ComputerEquipment2024-04-012025-03-3113858192core:NetGoodwill2024-03-3113858192core:NetGoodwill2025-03-3113858192core:NetGoodwill2024-03-3113858192core:FurnitureFittings2024-03-3113858192core:ComputerEquipment2024-03-31138581922024-03-3113858192bus:OrdinaryShareClass12024-04-012025-03-3113858192bus:OrdinaryShareClass12025-03-3113858192bus:OrdinaryShareClass12024-03-3113858192core:BetweenTwoFiveYears2025-03-3113858192core:BetweenTwoFiveYears2024-03-3113858192core:MoreThanFiveYears2025-03-3113858192core:MoreThanFiveYears2024-03-3113858192bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113858192bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3113858192bus:FRS1022024-04-012025-03-3113858192bus:Audited2024-04-012025-03-3113858192bus:Director12024-04-012025-03-3113858192bus:Director32024-04-012025-03-3113858192bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP